Drug Manufacturer

Syngene International Ltd Q4FY24; 6% rise in Profits

● Jul 9, 2024

Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be...

Neuland Laboratories Ltd Q4FY24; 20% fall in Profits

● Jun 19, 2024

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial...

Zim Laboratories Ltd Q1FY24; 96% fall in Profits

● Aug 14, 2023

Zim Laboratories Limited is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and...

Glenmark Life Sciences Limited Q3 FY23 Earnings Conference Call Insights

● Jan 30, 2023

Key highlights from Glenmark Life Sciences Limited (GLS) Q3 FY23 Earnings Concall Q&A Highlights: [00:13:44] Tarang Agrawal of Old Bridge...

Granules India Ltd (GRANULES) Q3 FY23 Earnings Concall Transcript

● Jan 24, 2023

Granules India Ltd (NSE: GRANULES) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Irfan Raeen — Investor Relation Advisor Krishna...

Gland Pharma Limited Q3 FY23 Earnings Conference Call Insights

● Jan 24, 2023

Key highlights from Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Management Update: [00:06:08] GLAND said the insulin line is...

Glenmark Life Sciences Limited Q2 FY23 Earnings Conference Call Insights

● Oct 27, 2022

Key highlights from Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Management Update: [00:02:53] GLS said that the demand...

Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript

● Oct 21, 2022

Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao — Head –...

Granules India Ltd (GRANULES) Q2 FY23 Earnings Concall Transcript

● Oct 20, 2022

Granules India Ltd (NSE:GRANULES) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate participants: Irfan Raeen — Investor Relation Dr....

Windlas Biotech Limited (WINDLAS) Q1 FY23 Earnings Concall Transcript

● Aug 5, 2022

Windlas Biotech Limited (NSE:WINDLAS) Q1 FY23 Earnings Concall dated Aug. 05, 2022 Corporate Participants: Hitesh Windlass — Managing Director Komal...